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Genetic suppressor elements (GSEs) are short biologically active gene fragments
that encode inhibitory antisense RNAs or truncated proteins that function as negative
dominants. GSEs can be constructed from a single gene or isolated from a multigene
library consisting of short random fragments of the target gene or genes.
The goal of this study was to determine if gene inhibition in bacterial cells could be
achieved by isolating GSEs from a genomic library. Additionally, if it was possible to use
GSEs to inhibit gene function in E. coli JM109DE3 cells, could this method be used to
locate and determine the function of unknown genes? In this study, antisense GSEs were
isolated clearly showing that it was possible to inhibit function of known and unknown
genes in bacterial cells using genetic suppressor elements derived from a genomic library.

VI

Introduction
Characterization of gene expression is an ongoing endeavor. To understand the
function of a particular gene, one can manipulate or mutate a gene such that it will alter
or inhibit the gene's expression and may lead to a specific phenotypic effect on the
organism. Classical mutation studies, although they reveal useful information, occur
randomly and this randomness makes it difficult to study individual genes
systematically (1).
The classic mutational approach to gene function involves use of chemicals or
radiation to alter genes at random. Cells and their progeny displaying altered
characteristics are isolated and then studied. This approach has been very successful with
microorganisms; however, it does not allow one to know the functional chromosomal
location of the mutated genes and does not insure that only one gene has been mutated.
For example, if a mutation inhibits a microorganism's ability to grow in the presence of a
particular sugar, it is not known whether this mutation is blocking one of the
microorganism's abilities to catabolize the sugar and/or inhibiting the cell's uptake of the
sugar. A large accumulation and classification of mutants is needed for understanding of
the complex biochemistry involved.
An alternative approach would be to use reverse genetics. Here, genes of interest are
inserted into a vector, which is then transformed into a cell or organism. The cloned gene
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is deliberately mutated and the phenotype observed to understand its function. One such
strategy is the production of genetic suppressor elements (GSEs).

Genetic Suppressor Elements
GSEs are short biologically active gene fragments that encode inhibitory antisense
RNAs or truncated proteins that dominantly inhibit the function of native protein subunits
(dominate negative mutants). These GSEs can be constructed from a single gene or
isolated from a multigene library consisting of short random fragments of the target gene
or genes cloned into an expression vector. Genetic information flows from DNA to
mRNA, which in turn is translated into a functional protein. Antisense RNAs bind to
mRNAs that are complementary in sequence and inhibit the genetic information flow at
the level of translation. Dominate negative mutants block the function of normal proteins
by associating with the wild-type monomer and rendering this monomer nonfunctional
(Figure I). Holzmayer and colleagues first noted GSEs in a study where GSEs were
produced by random fragmentation of the lambda DNA. This fragmentation inhibited the
functioning of specific genes involved in lambda-induced lysis of E. coli K12 cells (2).
Holzmayer's study described for the first time that a dominant, negative mutant GSE
designated Ea8.5 protected E. coli K12 from lambda-induced lysis.
In 1993, GSEs were generated from randomly fragmented human topoisomerase II
(Topo II) cDNA in order to isolate clones conferring resistance to etoposide. GSEs
encoding antisense RNA decreased cellular expression of the Topo II a-protein. Sense
and antisense GSE's isolated in this study were found to induce resistance to several
Topo II poisons.
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Figure 1. The Principles of Antisense RNA and Truncated Protein Inhibition.
1. The genetic information flows from DNA to mRNA, and then is translated into a
functional protein. 2. The function of the normal protein can be blocked by association
with the truncated protein. 3. The genetic information flow can also be blocked at the
translation level if an antisense gene, which has a sequence complementary to the
mRNA, is introduced into the cell.
Xinnan Nin, 1999, Inactivation of Glutamme Synthetase (glnA) and Putative Sulfate
transport (cysZ) Genes in E. coli by Antisense and Truncated Gene Strategies. Western
Kentucky University, Bowling Green, Kentucky Thesis
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Peptide-coding GSEs indicated structural domains of Topo II capable of independent
functional interaction. Two such areas include a N-terminal putative ATP-binding site
and the section between the active site and a leucine zipper region, which may be
involved in protein dimerization (3). Use of GSEs also demonstrated that it was an
efficient approach for selecting mammalian cells whose downregulation of kenesin
resulted in a selectable phenotype (4).
Genetic suppressor elements are useful in molecular oncology (5) and an effective
functional indicator of the multidrug transporter P-glycoprotein (6). It is clear that GSEs
are efficient tools that can illuminate the role of genes in both prokaryotic and eukaryotic
cells.

Dominant, Negative Mutants and Antisense RNA
An overview of the two types of genetic suppressor elements, antisense RNA and
dominant negative mutants, is essential in understanding the logic behind the use of
GSEs. Cloning of randomly fragmented DNA into a vector capable of transcription of
those fragments potentially produces two types of genetic suppressor elements. One such
type is a dominant, negative mutant and is expressed as a truncated form of a naturally
occurring protein (2). The truncated protein has the ability to interfere with the function
of the wild-type protein subunit activity in a dominant manner (3) by rendering one or
more functional domains inactive (Figure 1) (6). Truncated proteins that serve as
dominant negative mutants are most effective at inhibiting multimeric proteins (7).
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The other type of GSE generated during cloning of randomly fragmented DNA into an
expression vector is antisense RNA. These transcribed GSEs base pair with target mRNA
to inhibit protein synthesis (Figure 1). Antisense RNAs bound to mRNA may shield the
site from ribosome binding and thus prevent initiation of protein synthesis. Duplexed
antisense RNAs may also serve as a target for endonucelases, and therefore increase the
rate of mRNA turnover (1).

Dominant Negative Mutations Occurring in Nature
Since the initial suggestion by Herskowitz (8) that dominant negative mutations could
be used as a tool to study the functions of specific genes, it has become evident that these
mutations also occur naturally. In fact, a number of examples for this type of inhibitory
interaction in nature have been described.
One such example is the syndrome of thyroid hormone resistance in humans. Thyroid
hormone syndrome is an autosomal dominant disorder identified by high levels of
circulating thyroid hormone and organ resistance to the hormone (9). This disease is
caused by mutations in the £> form of the thyroid hormone receptor TR/3 , a nuclear
receptor that exerts its normal action by interacting with specific hormone-responsive
genes. The dominant negative effect of these mutations is due to their ability to form
nonfunctional heterodimers with wild-type TR/3, leading to the activation or repression
of target gene (9).
Another DNA binding protein that exerts a dominant negative effect is p53. Mutant
forms of p53 are common in several types of human cancer. Naturally occurring p53
mutants have been shown to inhibit the function of wild-type p53 by forming
heterodimers with wild-type p53. This effect appears to involve sequestration of these
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heterodimers in the cytoplasm, preventing the translocation of wild-type p53 into the
nucleus (10).
Dominant, negative mutations in the cytoplasmic tyrosine kinase domain of insulin
receptors have been identified in insulin resistant patients. The dominant negative effect
is exerted when the mutant receptor competes with wild-type receptors and interferes
with the initiation of the signaling cascade during receptor dimerization (11).

Mechanisms of Dominant Negative Mutants
Variants of wild-type proteins that are overproduced have the ability to inhibit protein
function. These variants can be designed, because their proteins have multiple functional
sites that can be mutated independently (8). Some examples of the functional sites that
can be targeted for mutation are oligomerization sites, substrate-binding sites and
catalysis sites.

Proteins mutated within a functional site are capable of interacting with

their wild-type protein counterparts and interfere with the normal function of the wildtype and thus function as a dominant negative mutant. If a multimeric enzyme's active
sites or regulatory sites are known or can be inferred, then it is possible to make specific
mutations that may generate dominant negative mutants. These specific mutations can be
useful in identification of active domains in a protein.
Gene-regulatory proteins such as the lac or trp repressors bind to DNA as dimers to
regulate their respective target operons. Removing the carboxy-terminal end responsible
for DNA binding (12) can produce a dominant negative version of the trp repressor.
DNA-binding proteins utilize sequence motifs such as the 'helix-turn-helix' (13,14) as
their DNA-binding domain. Removal of part or the entire motif sequence can produce a
dominant negative mutant.
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Another mode of inhibition by DNA-binding proteins turns transcription activators
into repressors (8). An example of this mode of inhibition is the x gene of the human Tcell leukemia virus HTLV-II. Mutations in the HTLV-I1 transcription activator have been
shown to block the wild-type protein's activation of transcription (15).
Studies of hybrids formed between E. coli aspartate transcarbamylase wild-type and
mutant subunits illustrate two separate ways that mixed aggregates can inhibit enzyme
function (8). First, mutants modified within the active-site residues can associate with
wild-type subunits to form nonfunctional aggregates (16) because the active site of the
enzyme is composed of residues from adjacent subunits (17). Second, subunits with
modifications outside the active site can inhibit enzyme function when mixed aggregates
fail to respond to the binding of a ligand because the protein is in an inactive
conformation (18). Enzymes with multiple subunits and catalytic sites at subunit
interfaces such as the glutamine synthetase (12 subunits) would be very sensitive to
aggregation with mutant subunits (19).

Prokaryotic and Eukaryotic Antisense RNAs in Nature
Many antisense RNAs occur in nature, and act as regulational elements in both
prokaryotic and eukaryotic systems. The first prokaryotic antisense RNA inhibitor
identified was the micF RNA in E. coli. The micF RNA is complementary to the ShineDai garno site and the initiation codon of the ompF mRNA (20,21). The micF inhibition
of the ompF gene is induced by high temperature, the presence of salicylate, and
mutations at the mar A or tolC loci (22).
The antisense RNA dicF is part of an operon that has six open reading frames and
inhibits the ftsZ gene that codes for a protein involved in an early step of cell division in
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E. coli. FtsZ is a membrane-associated protein that binds and hydrolyzes GTP. DicF
RNA inhibits ftsZ gene expression at the post-transcriptional level when its RNA binds to
ftsZ mRNA at the Shine-Dalgarno ribosomal binding site and AUG translational start
sequences (23).
The DNA region coding for glutamine synthetase in C. acetobutylicum contains an
antisense promoter (P3) located downstream from the sense promoters Pi and P2 The P3
promoter controls the transcription of an antisense RNA, complementary to a 43-base
region encompassing the ribosomal binding site and the initiation codon at the 5' end of
the glnA mRNA (24).
Another example of natural antisense regulation involves inhibition of replication in
the plasmid pT181. Two antisense RNAs (RNA I, RNA II) which are complementary to
the RepC mRNA leader sequence induce premature termination of transcription by
altering mRNA secondary structure conformation. The RepC protein whose RNA is
transcribed from two different promoters producing RNA III and RNA IV. RNA 1 and
RNA II differ at their 3' ends which are complementary to the 5' untranslated regions of
the mRNA coded by RNA III and RNA IV (25).
Some mobile genetic elements have been found to use antisense inhibition as a control
mechanism. Tn/0 is a composite transposon that encodes a transposase, tnp, located in
each terminal IS 10. A promoter, RNA-OUT, is adjacent to and oriented in the opposite
direction to the tnp promoter, RNA-IN, and produces an overlapping complementary
transcript that blocks the ribosomal binding site of the tnp mRNA. Blocking the tnp
ribosomal binding site inhibits transposase production and therefore limits the mobility of
these genetic elements (26, 27).
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Bacteriophages have also been found to use naturally occurring antisense RNAs to
regulate lysogeny. The temperate bacteriophages PI and P7 produce antisense RNA that
inhibits antirepressor (Ant) synthesis which is essential for establishment and
maintenance of lysogeny (28). Other temperate bacteriophages such as P22 and Lambda
use antisense RNA to inhibit gene expression. P22 uses antisense'RNA to inhibit the
expression of the ell gene where as Lambda uses antisense RNA to inhibit the expression
of the cro gene. Both the ell and cro genes promote the lytic cycle (29).
Antisense RNA has been found to regulate HIV-1 gene expression of the env gene.
Sequences in the rev-response element overlap the env gene and arrest translation of the
HIV-1 envelope (30,31,32,33, and 34). The predominance of eukaryotic gene loci,
which transcribe both sense and antisense RNA species have only recently been
acknowledged. The high frequency of in-phase open reading frames in the antisense
strands of recognized eukaryotic gene sequences suggests that the number of reported
natural antisense RNAs will continue to grow (35). One known example includes
regulation of transcriptional elongation in the N-/wyc gene by the N-cym antisense RNA
(36). Also, translational control of the myosin heavy chain is regulated by two isoforms
of the tcRNA102 (A and B) from chicken muscle which show a significant amount of
homology to the 5' end of the myosin heavy chain mRNA (37).

Mechanisms and Applications of Artificial Antisense RNA
In 1963, Singer and others demonstrated that inhibition of translation was due to an
antisense element (39,38). Singer and his colleagues showed that phenylalanine
synthesis was completely blocked if polyadenylic acids were present in a cell-free
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translation reaction system (39). Other reports also confirmed that many RNAs
complementary to cellular RNA blocked translation. (40).
In 1977, Patterson et al. developed a method termed hybrid-arrested-translation or
H. A.R.T which demonstrated that the translation of /3-globin mRNA was reversibly
inhibited when it was hybridized with denatured DNA from a recombinant plasmid,
P/3G1, which carried the 9S rabbit globin gene. (41). Using the H. A.R.T. method allowed
Patterson and his colleagues to map structural and regulatory sequences in adenovirus 2
(41). A few months later, Hastie and his colleagues looked at mRNA populations (42)
through hybridization of mRNA to their corresponding cDNA which specifically
inhibited the translation of the mRNA in vitro (42). Equivalent amounts of globin cDNA
and mRNA were required to inhibit globin synthesis completely. Also, it was found that
the rate of inactivation was identical to the rate of hybridization between globin cDNA
and globin mRNA (42).
The hybrid-arrested-translation method involved DNA-RNA hybridization after
double- stranded DNA was denatured through heating and then annealed to mRNA. This
strategy blocked translation of the mRNA, however, both the Patterson and Hastie studies
were conducted within cell free systems. Still to be resolved was the problem of how to
achieve this effect in intact cells.
In 1984, a method for inhibiting mRNA in intact cells was developed (43). Pestka and
colleagues constructed a plasmid that could generate mRNA that was complementary to
/3-galactosidase mRNA. In this study, /3-Galactosidase protein production was inhibited
by 98%, the galactoside permease by 80% and the transacetylase by 55% (43). These
studies began the application of antisense technology.
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The mechanisms of antisense RNA inhibition have been divided into three classes
based on the location of antisense RNA binding on the mRNA. Class I antisense RNAs
are directly complementary to the Shine-Dalgarno sequence and/or coding regions of the
target mRNA (44). Most antisense RNAs belong to Class I. Class I RNAs are divided
into two subclasses. One of the subclasses contains antisense RNA that binds directly to
the Shine-Dalgarno sequence and/or the coding region on target mRNA and inhibits
translation. The other, Class IB antisense RNA, destabilizes the target mRNA and renders
it susceptible to nucleases (44).
Class II antisense RNAs bind to a region upstream from the Shine-Dalgarno sequence.
This class of antisense RNA exerts a secondary effect by binding to regions far from their
functional targets. Such regulation by class II RNAs is considered to be due to refolding
of an RNA molecule and as a result of a hybrid formation occurring at a region far from
the target site. Class II antisense RNAs are the most difficult to design. The difficulty
arises because Class II-type antisense RNA regulation has a limited availability of the
target mRNA and the complicated requirement of RNA folding (44).
Class III antisense RNA function at the transcriptional level by mimicking the Rhofactor-independent transcription termination signal. The antisense RNA hybridizes to the
mRNA upstream from a stretch of Us, forming a double-stranded RNA region that is
recognized by the RNA polymerase as a transcriptional termination signal which causes
premature transcription termination (45).
Artificially designed antisense RNAs have been used to inhibit gene function for a
number of different applications such as plants (46,47,48,49, 50), pharmaceutical
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agents (51,52), microorganisms used in the environment (53), gene therapy for hepatitis
B viral infection (54) and pathogenic genes carried by bacteria (55).

Experimental Approach
The genome of E. coli K12 was entirely sequenced in 1997 and of the 4,288 protein
coding regions identified, 38 % were found to have no known function (56). Sequencing
of the entire genome of E. coli K12 provided an excellent opportunity to explore the
power of genetic suppressor elements (GSEs) in mapping cell functions to specific genes.
The objectives of this study were to: 1. Determine if GSEs would inhibit gene functions
related to growth of E. coli on minimal media, 2. Identify the gene that was related to the
GSE, and 3. To determine if any of the isolated genes had an unknown function assigned
to them, thus, justifying further investigation.
The experimental approach was patterned after Holzmayer et al. (2), which was
effective in identifying a previously unknown gene in the lambda phage. In this study,
E. coli JM109 DE3 DNA was randomly fragmented, size selected, and cloned into a
plasmid vector, such that the fragments could be inserted in either the coding or antisense
orientation relative to the T7 RNA polymerase promoter. The recombinant vectors were
then transformed back into the E. coli JM109 DE3 cells to form a library of plasmids
carrying genomic DNA. The E. coli JM109 DE3 strain was chosen as a host because it
carried a T7 RNA polymerase gene downstream of an IPTG inducible lactose promoter
and allowed transcription of the GSE from the vector's T7 RNA polymerase promoter
whenever IPTG was present and T7 RNA polymerase expressed. E. coli JM109 DE3
cells transformed with clones from the genomic library were plated on rich media and
then replica plated onto minimal media containing IPTG and without IPTG. Colonies that
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grew on the plates without IPTG but grew either slowly or not at all on the plates with
IPTG were said to carry a GSE.
GSE containing plasmids were further analyzed for GSE length by digestion with
restriction enzymes. The nucleotide sequence of the GSE was also determined, and the
sequence was matched to a location on the E. coli genome. Any known or putative
functions for the identified GSE were noted. Finally the GSE was identified as being in
either the sense or antisense orientation relative to plasmid T7 promoter, and the various
mechanisms of inhibition were explored for each clone.

Methods and Materials
Vector Construction
The vector used in this study was a hybrid plasmid, pAV, constructed by Todd
Holland at Western Kentucky University from fragments of the plasmids pGEMEX™2
and pGEMR-3 (Promega, Madison WI.) (Figure 2). The first section of pAV consists of
the small Sea I to Hind III fragment from pGEMX™2 and harbors part of the ampicillin
resistance gene, the fl origin of replication, a T7 transcription terminator and the Sp6
RNA polymerase promoter. The large Sea I to Hind III fragment from the pGEMR-3
plasmid includes the end of the multiple cloning site, the T7 RNA polymerase promoter,
a ColEl origin of replication and two thirds of the ampicillin resistance gene.

Growth and Isolation of Plasmids
Isolation of the plasmid vector was done according to the large, scale plasmid prep
protocol found in Protocols and Applications Guide (57).

Phenol Extraction and Ethanol Precipitation
To remove protein from the plasmid, 1 volume of TE (10 mM Tris-HCl pH 8.0, ImM
EDTA pH 8.0) saturated phenol/chloroform/ isoamyl alcohol (25:24:1) (58) was added to
the lysate and shaken to extract the plasmid before being centrifuged at 12,000 x g for 15
minutes. The white precipitate at the interface of the phases was carefully avoided and
the aqueous phase was transferred to a sterile tube.

- 14-
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Figure 2. Construction of pAV Vector: The gray outlined Sea I / Hind III segments
from pGEM-3 & pGEMEX-2 were ligated together to produce the pAV vector.
Xinnan Nin, 1999, Inactivation of Glutamine Synthetase (glnA) and Putative Sulfate
transport (cysZ) Genes in E. coli by Antisense and Truncated Gene Strategies. Western
Kentucky University, Bowling Green, Kentucky Thesis

Two volumes of ice cold 95 % (v/v) ethanol were added to the aqueous phase which was
incubated at -80°C for 30 minutes and then centrifuged at 12,000 x g for 15 minutes to
pellet the plasmid DNA. This pellet was washed with 2-3 mL of ice cold 70 % (vol/vol)
ethanol and re-centrifuged at 12,000 x g for 10 minutes. Following the centrifugation, the
DNA pellet was dried under vacuum for 10 minutes and then resuspended in 500 jjL of
nuclease free water. RNase One (5 units for 1 hour at 37°C) (Promega) was used to
remove any residual RNA, and the plasmid was purified a final time using the phenol
extraction/ethanol precipitation procedure just described.

Agarose Gel Electrophoresis
Agarose gels were prepared according to Maniatis et al (59), except that 2.5 /LiL of
lOmg/mL ethidium bromide was added to each 50 mL agarose gel. Gels were
electrophoresed at 100 volts for about 1-1.5 hours in a IX TBE buffer (0.089 M Tris,
0.089 M Boric acid, 2.0 mM EDTA, pH 8.0). The DNA was visualized under UV light
using the Kodak Digital Science image analysis system.

Linearization and Dephosphorylation of pAV
Linearization and dephosphorylation of plasmid DNA were carried out according to
the protocol found in Protocols and Applications Guide from Promega (60). The plasmid
linearization consisted of digesting the plasmid vector with BamH I restriction enzyme at
0.5 units/jjg DNA and IX BamH I restriction enzyme buffer (New England Biol abs)
then incubated at 37°C overnight. Linearization was confirmed by agarose gel
electrophoresis.
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Linear plasmid was dephosphorylated using shrimp alkaline phosphtase (USB)
O.Olunits/pmol DNA end, and IX shrimp alkaline phosphotase buffer and incubated at
37°C for 90 min. The shrimp alkaline phosphotase was inactivated by heating the
reaction mixture in a hot water bath at 65°C for 15 minutes. The reaction mixture was
then extracted once with an equal volume of phenol and ethanol precipitated as described
above.

Isolation and Purification of Genomic DNA
Isolation of genomic DNA was carried out using the procedure found in Current
Protocols (61). A single colony of JM109 DE3 cells (Promega, Madison, WI) was used
to inoculate 2 mL of LB broth (1% w/v bacto-tryptone, 0.5 % w/v bacto-yeast extract, 1%
w/v NaCl) and grown overnight at 37°C with shaking at 250 rpm. An aliquot of 1.5 mL
of this overnight culture was used to inoculate 500 mL of LB/broth and grown overnight
at 37°C with shaking at 250 rpm. The 500mL cell culture was centrifuged at 10,000 X g
for 10 minutes to pellet the cells. The supernatant was discarded, and the cells were
resuspended with 47.5 mL of lx TE. Next, 2.5 mL 0.5 % SDS (w/v) and 250 fjL of
proteinase K (20mg/mL) were added and mixed thoroughly. The suspension was
incubated at 37°C for 1 hour. After incubation, 9 mL of 5 M NaCl was added and
thoroughly mixed. Seven and one half milliliters of 1% (w/v) hexadecyltrimethyl
ammonium bromide (CTAB) solution and 80 mL nuclease free water was added, mixed
and incubated at 65°C for 20 minutes.
An equal volume of chloroform/isoamyl alcohol (24:1) was added to the cell lysate
and centrifuged at 6,000 x g for 10 minutes. The upper aqueous phase was transferred to
a sterile tube, and 0.6 volumes of isopropanol were added to precipitate the
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DNA. The precipitated genomic DNA was removed using a bent glass rod and
transferred to a sterile, centrifuge tube containing 5 mL 70 % (v/v) ethanol. The DNA
was centrifuged at 10,000 x g for 5 minutes; the genomic DNA pellet was vacuum dried
for 10 minutes, the pellet was resuspended with 4 mL of TE and transferred to a sterile
culture tube. The concentration of genomic DNA was adjusted to 100 yg/ mL with TE;
then to 8 mL of solution, 8.6 g of cesium chloride along with 400 L of lOmg/mL
ethidium bromide were added and transferred to ultracentrifuge tubes. The density of the
CsCl/ETBr solution was 1.55 g/mL. The tubes were centrifuged in an ultracentrifuge at
145,000 x g at 15°C for 24 hours. The gradient was then visualized under an UV lamp,
and the genomic DNA band was removed and placed in a sterile tube. Ethidium bromide
was removed by sequential extractions with water-saturated butanol until the ethidium
bromide was visibly removed. The DNA was dialyzed overnight against 2 liters of TE.
The DNA solution was transferred to a fresh tube and precipitated by adding 1/10 volume
of 3 M sodium acetate and 0.6-volume isopropanol. Precipitated genomic DNA was
centrifuged at 10,000 x g for 10 minutes and the pellet resuspended in nuclease free
water.

Partial Digestion of Genomic DNA
Partial digestion of genomic DNA was based on the procedure found in Applications
and Protocols (62). The 400 )jL of digestion reaction mix contained 175 IJg genomic
DNA, 40 jjL lOx Sau3A I restriction enzyme buffer and 50 units Sau3A I restriction
enzyme (New England Biological). The reaction was incubated at 37°C and a 10 /JL
aliquot was removed each hour for electrophoresis to determine digestion status.
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Isolation of Genomic DNA Fragments
Size fractionation of the genomic DNA was accomplished by passing the fragments
over a Sepharose CL-4B column (63). Ten milliliters of pre-swollen Sepharose CL-4B
(Sigma) and 35 mL CL-4B column buffer (.01 M Tris-Cl, pH 8.0, 0.6 M NaCl,
0.001 M EDTA, pH 8.0, 0.5 % w/v Sarkosyl) was added to a 50 mL centrifuge tube then
mixed and allowed to settle by gravity for 10 minutes. The column buffer was aspirated
to remove any unsettled fines. This process was repeated two additional times. Fresh CL4B column buffer (lOmL) was added, mixed by inversion several times and incubated at
37°C for 10 minutes to avoid outgassing during column assembly. A 5 mL plastic pipet
was used as the column with silanized glass wool placed into the tip of the pipet to act as
a filter. The Sepharose was added to the column to a total volume of 5 mL, and the
column was washed with 15 mL of CL-4B column buffer to ensure even packing of the
Sepharose and to establish a constant flow rate of 1 mL/minute. The fragmented genomic
DNA (280 jjL) was added to the column and fractions of 5 drops (170 jjL) were
collected. A 10 /jL aliquot of each fraction was electrophoresed on an agarose gel
electrophoresis to determine which fractions harbored the desired fragment range. Those
fractions with the desired fragment sizes were pooled and purified by the phenol
extraction/ethanol precipitation method described above.

Ligation of DE3 fragments to the pAV Vector
Ligation of the genomic DNA fragments to the linear, dephosphorylated plasmid was
done according to the protocol found in Protocols and Application Guide (64). Reactions
were setup in a total volume of 10 jjL containing 1/jg of dephosphorylated pAV and
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363 ng of genomic DNA fragments, 20 units T4 DNA ligase (New England Biological),
and 1.0 fiL of lOx T4 DNA ligation buffer (66 mM Tris-HCl, pH 7.6, 6.6 mM MgCl2,
LOMM

DTT, 66 pM ATP). Reactions were incubated at 16°C overnight. A

3 /JL

aliquot

from each reaction was electrophoresed on an agarose gel to determine the ligation status.

Transformation by High-Efficiency Electroporation
Transformation of the recombinant plasmid vector into bacterial cells followed the
procedure found in Current Protocols (65). A single colony of E. coli JM109 DE3 was
inoculated into 5 mL LB broth and grown overnight at 37°C with shaking at 250 rpm. A
2.5 mL aliquot of this overnight culture was used to inoculate 500 mL of LB broth and
grown at 37°C with shaking (250 rpm) to an OD 0.6. The cells were chilled in an ice bath
for 10-15 min and then centrifuged at 3000 x g for 20 minutes at 4°C to pellet the cells.
The supernatant was discarded and the pellet completely resuspended with 5 mL sterile
nuclease-free water. To render the bacterial cells electrocompetent, the cells were wash 2
times using 500 mL of chilled, sterile, nuclease-free water. The cells were centrifuged at
3000 x g for 10 minutes at 4°C. The final cell pellet was resuspended with 5 mL of
chilled sterile water and transferred to a sterile, pre-chilled tube and then centrifuged at
3000 x g for 10 min at 4°C. The pellet volume was estimated visually and the cells were
resuspended in an equal volume of chilled, sterile, nuclease-free water. The cell
suspension was transferred in 100 /jL aliquots to sterile pre-chilled 1.5 microcentrifuge
tubes and kept on ice.
The electroporation apparatus was set at 1260 volts and 400 ohms. Recombinant
plasmid 0.5 ng was added to 100 (jL electrocompetent cells. The entire mix was
transferred to a sterile pre-chilled electroporation cuvette with a 1mm gap and placed on
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ice for 5 minutes. The cuvette was then placed into the sample chamber of the
electroporation apparatus and the current was applied. The cells were then transferred to
1 mL SOC medium (0.5 % w/v yeast extract, 2 % w/v tryptone, lOmM KC1, lOmM
MgCl2, lOmM MgS0 4 , 20mM glucose) and incubated for 60 min at 37°C with moderate
shaking at 250 rpm. Aliquots of the transformed cells were plated onto LB plus
ampicillin (50 mg/mL) agar plates to determine transformation efficiency and titer.

Amplification and Titer of the Genomic DNA Library
Protocol for amplification of the genomic DNA library was found in Current
Protocols (66). The library of recombinant cells was amplified by diluting 900 /jL of
transformed cells with 35 mL of LB broth plus ampicillin (50 /Jg/mL) and grown
overnight at 37°C with shaking at 250 rpm. The amplified library was prepared for
storage by adding 6.75 mL of sterile 100 % v/v glycerol and 3.25 mL sterile nucleasefree water, raising the total volume to 45 mL. The amplified library was transferred to
sterile microcentrifuge tubes in 1 mL aliquots per tube and stored at -80°C for future use.
To obtain the titer, a 100 JJL aliquot of the amplified library was serially diluted from
10"1 to 10"10 with sterile, nuclease-free water. Aliquots of 100 ijL from each dilution were
plated onto LB plus ampicillin (50 yg/mL) agar plates. The titer plates were grown
overnight at 37°C. The titer was determined using the protocol found in Current
Protocols (66).

Screening the Genomic DNA Library by Replica Plating
Replica plating of the genomic DNA library was carried out according to the replica
plating protocol found in Current Protocols (66). Aliquots of 100 JJL of diluted genomic
DNA library stock (dilution 1/10,000 to give between 50 and 100 colonies per 100 mm
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diameter plate) were plated out onto 20 LB agar plates containing ampicillin (50 /jg/mL).
These plates were grown overnight at 37°C and used as master plates. Colonies from the
master plates were transferred to sterile velveteen squares (Scienceware) and replica
plated onto minimal agar plates (1 % wt/vol minimal media (Difco), 1 mM proline, 1 mM
thiamine-HCl, 50 /Jg/mL ampicillin, 1.5 % w/v agar) with and without 0.5 M IPTG. All
plates were grown overnight at 37°C.
Colonies grown on plates with IPTG were compared to the colonies grown on plates
without IPTG to determine if gene suppression had occurred. Those colonies that grew on
the plates containing IPTG that did not grow or that grew slower on plates without IPTG
were isolated for further analysis.

Isolation and Analysis of Plasmid Vector
Isolation of the plasmid vectors that contained genomic DNA inserts was carried out
using a scaled down version (from 500 mL to 100 mL ) of the large-scale plasmid preps
found in Protocols and Applications Guide from Promega (57). The colonies found on
minimal plates without IPTG that corresponded to those colonies that did not grow or
grew slower on minimal plates with IPTG were selected and their plasmids isolated by
the method mentioned above.
Restriction digests were used to determine if genomic DNA inserts were incorporated
in the vector. These reactions contained 1 /jg of plasmid DNA, EcoR I and Hind III at
1.0 units/jjg DNA for each restriction enzyme (New England Biol.) and 1.0 /JL of 10X
restriction enzyme buffer in a final volume of 10 yL. The reactions were incubated
overnight at 37°C, and the restriction fragments were separated and visualized by agarose
gel electrophoresis.
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DNA Sequencing and Analysis
DNA sequencing procedures were carried out according to the protocol included in
the 77 Squenase 2.0 sequencing kit (Amersham Life Sciences). This protocol is based on
the Sanger dideoxynucleotide sequencing method (67). The primers used were
complementary to either the T7 RNA polymerase promoter or the SP6 RNA polymerase
promoter. The isotope used was [«- j3 S] dATP with a specific activity of 1000-1500
Ci/mmol. The gel was exposed to X-ray film (Fuji) for 5 days. The film was developed in
GBX developer for 2 minutes and GBX fixer for 5 minutes.
DNA sequences were compared to the E. coli sequence database (56) using the blast
search program (68). E. coli sequences that matched to isolated GSE insert sequences
were analyzed to ascertain the type of GSE that was involved in possible gene
suppression. The main characteristic used to determine the type of GSE involved was
accomplished by determining the orientation in which the GSE sequence matched to the
E. coli gene sequences. Sequences matching in the sense orientation were considered
dominant negative mutant GSEs. Those sequences matching in the antisense orientation
were considered antisense RNA GSEs.

RNA Secondary Structure Analysis
The RNA secondary structure for each gene was predicted using an RNA folding
algorithm from Mathews el. al. (69). This algorithm is based on free energy minimization
using the nearest neighbor parameters. Predicting a structure is a two-step process. First,
a recursive algorithm generates an optimal structure and a series of structures that are
called sub-optimal structures (69). The number of sub-optimal structures generated is
controlled by three parameters determined by the user, maximum % energy, maximum
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number of structures, and window size. Maximum % energy sets the percent difference
from the lowest free energy allowed for the structure output. Maximum number of
structures sets an absolute upper limit on the number of structures (1000) that can be
generated. Window size controls how different the sub-optimal structures must be from
each other. A small window size allows very similar structures to be generated while a
larger window size requires them to be more different (69).
Second, structure favorability is re-ordered. Here, the energy of each structure is recalculated using a function that includes coaxial stacking of helixes and a JacobsonStockmayer function for determining the free energy of large loops. The output is then
sorted according to the recalculated free energy (69). The parameters used to create
localized RNA secondary structures for those E. coli genes that matched to any GSE
transcripts produced in this study are as follows: Max % energy difference = 10, Max
number of structures = 1000 and Window size = 3.

Results
Isolation, Linearization and Dephosphorylation of pAV Vector
The pAV vector was isolated from a large-scale plasmid preparation of 500 mL of
cells. The plasmid DNA was purified to a 260nm/280nm ratio value of 1.79 and gave a
yield of lmg of purified plasmid DNA.
The vector pAV was linearized using 200 units BamH I restriction enzyme per 400
)jg of pAV in a 300 /uL reaction. The reaction was incubated at 37°C overnight.
Linearization was determined by agarose gel electrophoresis and a 3000 bp fragment was
obtained (Figure. 3 lane 3).
Dephosphorylation of pAV was a critical step in preventing any religation of the pAV
vectors to itself. A total of 200 jug of linearized pAV vector was dephosphorylated with
16 units of shrimp alkaline phosphatase in a 200 fjL reaction. The reaction was incubated
at 37°C for 1 hour and heated to 65°C water bath for 15 minutes to inactivate the shrimp
alkaline phosphtase.

A test ligation was performed to determine if the dephosphorylation of pAV was
efficient. The control ligation contained 200 ng of linear, dephosphorylated pAV without
ligase in a 10 ^/L reaction, and the experimental ligation contained 200 ng linear pAV
with ligase. Both reactions were incubated at 16°C overnight and analyzed by agarose gel
electrophoresis (Figure 3, lanes3 & 4, respectively).
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Figure 3. Gel electrophoresis of linearized pAV, and partially digested E. coli JM109
DE3 genomic DNA. The electrophoresis was carried out on a 0.8 % w/v agarose gel.
Lanes 1 & 6 are lkb markers (BRL). Lane 2.Uncut pAV: Lane 3. Linear pAV; Lane 4
shows dephosphorylated pAV after self-religation: Lane 5. Partial digestion of JM109
DE3 genomic DNA after 3.0 hours:

Isolation and Partial Digestion of E. coli JM109 DE3 Genomic DNA
Genomic DNA was isolated from a 500 ml overnight culture of E'. coli JMI09 DE3.
Purification of the JMI09 DE3 genomic DNA was performed using a cesium
chloride/ethidium bromide gradient and centrifuged at 145,000 x g for 24 hours. The
ethidium bromide was extracted with water-saturated butanol, and the cesium chloride
was removed by dialysis. A yield of 175 /jg of genomic DNA was obtained with a
260nm/280nm ratio of 1.81.
JM109 DE3 genomic DNA (175 /jg) was digested with 50 units of Sau3A 1 restriction
enzyme in a total volume of400 /jL. Aliquots of 10 JJL were drawn at 1.0 hour intervals,
and the progress of digestion was determined by gel electrophoresis. Figure 4 shows the
partial digestion at 1.0 hour and reveals that the majority of the JM109 DE3 genomic
DNA fragments lie between 6000 and 1000 bp. Figure 5, at 2.0 hours of digestion, shows
a range of fragments from approximately 3500 bp to 400 bp. A partial digestion for 3.0
hours was found to generate the majority of the DNA fragments between 1000 bp and
250 bp which was the desired fragment range (Figure 6).
Fragmented JM109 DE3 genomic DNA was purified by phenol extraction/ethanol
precipitation. The fragmented genomic DNA was size fractionated (130 jug in 280 ijL) on
a CL-4B Sepharose column and fractions of 170 /JL (5 drops) were collected. A 10 IJL
aliquot was removed from each fraction, and fragment sizes were determined by gel
electrophoresis (Figure 7). Fractions 13-16 were pooled and purified by phenol
extraction/ethanol precipitation and used in the ligation to the pAV vector.
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Figure 4. Electrophoresis of a 1.0 hour Sau3A digestion of JM109 DE3 genomic
DNA on a 0.8 % agarose gel: Lane 1 & 4: lkb marker (BRL). Lane 2: uncut JM109
DE3 genomic DNA. Lane 3: DE3 genomic DNA partially digested for 1.0 hour.
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Figure 5. Electrophoresis of a 2.0 hour digestion of JM109 DE3 genomic DNA on a
0.8 % agarose gel: Lane 1 & 3: Ikb marker (BRL). Lane 2: partially digested JM109
DE3 genomic DNA.
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Figure 6. Electrophoresis of a 3.0 hour Sau3A digestion of JM109 DE3 genomic
DNA on a 0.8 % agarose gel. Lane 1: DE3 genomic DNA partially digested after 3.0
hours. Lane 2: lkb marker (BRL).
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Figure 7. Electrophoresis of fractionated JM109 DE3 genomic DNA on a 0.8 %
agarose gel: Lane 1 & 21: lkb markers (BRL). Lanes 2-11: No DNA resolved in
fraction. Lanes 12-20: Fractions volumes of 170 pL were collected from CL-4B
sepharose column. Fractions 13 through 16 were purified and used for the ligation
reaction. These fractions were chosen because the DNA fell within the desired fragment
range of approximately 50 to 1500 bp.

32

Ligation and Transformation of DE3 genomic DNA to pAV
Ligation reactions incorporated six controls and two experimental reactions as
illustrated in Table 1. Control 1 contained 10 iL water, control 2 contained uncut pAV,
serving as a negative and positive transformation controls, respectively. Controls 3 and 4
contained linear pAV without and with T4 DNA ligase, respectively. These controls
tested the overall ligation efficiency and the ability of linear pAV to self-Iigate. Controls
5 and 6 consisted of dephosphorylated pAV, with no T4 DNA ligase and with T4 DNA
ligase, respectively. These controls determined the dephosphorylation efficiency by
testing the ability of dephosphorylated pAV to self-ligate in the presence of T4 DNA
ligase. Two experimental ligation reactions were set up with a 1:1 molar ratio of vector to
insert and a 1:2 molar ratio of vector to insert.
A 3 juL aliquot was taken from each control and experimental reaction and
electrophoresed to determine the ligation status (Figure 8). Dark bands in figure 8 greater
than 4000 bp, illustrate JM109 DE3 fragments ligated into the dephosphorylated pAV
(Figure 8 lanes 11 & 12). In contrast, the dephosphorylated vector did not ligate (Figure
8, lanes 9 & 10) and no bands above 5000 bp were obtained. Linearized pAV controls
showed a faint band in control 3 (Figure 8 lane 6) and no distinct bands for control 4
(Figure 8 lane 8).
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Table 1. Components used in ligation reactions.
control 1

control 2

control 3

control 4

No vector

Uncut
pAV

Linear
pAV
no ligase

Linear
pAV
With
ligase

Dephosph
pAV
no
hgase

Dephosph
pAV
with
hgase

JM109
DE3
1:1
molar
ratio

JM109
DE3
1:2
molar
ratio

lyL
200ng

ILJL
200ng

1/JL
200ng

l^L
200ng

4vL
l^g
1/JL
181ng

4nL
l^g
363ng

lvL

\UL

PAV

200ng
JM109
DE3
Fragment
T4
buffer
lOx
T4
Ligase

control 6 Ligation-1 Ligation-2

l^L
2fuL
ut[i L

*>-

10 W/JUL

DH2O
Totals

control 5

10/JL

9jjL
10/JL

10/JL

6^L
10^L

10

10^L

6/JL
10(jL

2liL
10 W//JL

2/JL
\o^L

2(jL
u/yL

10

IJJL

10/uL
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Figure 8. Electrophoresis of ligation reactions on a 0.8 % Agarose gel:
Lanes 1,7 & 13: 1 kb markers (BRL). Lane 2: uncut pAV. Lane 3: linear pAV. Lane 4:
No vector. Lane 5: Uncut pAV. Lane 6: linear pAV without ligase. Lane 8: Linear pAV
with ligase. Lane 9: Dephosphorylated pAV without ligase. Lane 10: Dephosphorylated
pAV with ligase. Lane 11: a 1 :lmolar ratio experimental ligation. Lane 12: a 1:2 molar
ratio experimental ligation. Lanes 15 & 16: previous experimental ligations. Lanes 2 and
3 are controls that did not go through the ligation reaction and were used for comparison
to lanes 5 and 6.

Once successful ligation was confirmed, the ligation mix was transformed into
E. coli JM109 DE3 cells. Transformation was carried out by electroporation using 0.5 ng
of recombinant pAV added to 100 /jL electrocompetent DE3 cells. Transformation
efficiency and titer were determined by serially diluting transformed cells and plating 100
IJL of the diluted cells onto 7 LB/ampicillin (50/jg/^L) agar plates per reaction. All plates
were incubated at 37°C overnight and colonies counted.
Table 2 shows the number of colonies per plate and the resulting transformation
efficiencies and titer. Transformation with the negative control (No vector) produced no
colonies and the positive control (uncut pAV) produced the most colonies with a
transformation efficiency of 109 (Table 2). Analysis of transformation efficiencies for
linear pAV without ligase vs linear pAV with ligase shows that linear pAV was able to
religate to produce efficiencies rivaling the uncut control, thus indicating that the ligation
efficiency was very good.
Examination of the dephosphorylated pAV with and without ligase shows that
dephosphorylated pAV was able to religate to some degree and therefore not all of the
pAV molecules were dephosphorylated and will appear as unproductive background.
Unproductive background clones in the 1 :land 1:2 libraries appear at the rate of 14 %
and 10 % respectively (Table 2). Transformation values obtained for the 1:1 and 1:2
molar ratio of vector/insert were comparable to the control values for uncut pAV and
religated linear pAV (Table 2). This similarity is an indication that the ligation of
dephosphorylated pAV and DE3 genomic inserts were successful, and contained a low
background (10 — 14 %) for dephosphorylated pAV self ligation.
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Table 2. Transformation Results.
Dilutio
n

No vector

IO-1

0

Uncut
pAV

Linear
pAV
no ligase

Linear
pAV
With
hgase

Dephosph
PAV
No
Ligase

Dephosph
pAV
with
ligase

TNTC

17

TNTC

>300

0

TNTC

0

TNTC

0

>300

0

10-4

0

29

10*

0

10-6
*

1:1

1:2

>300

TNTC

TNTC

21

76

TNTC

TNTC

>300

7

15

101

145

0

18

0

4

11

23

6

0

1

0

0

2

3

0

0

0

0

0

0

0

0

0

6.4 x 109

3.7 x 106

4.0 x 109

4.6 x 107

1.7 x 108

2.4 x 109

3.3 x 109

0

2.9 x 10*
in a total
of 1 mL

1.7 x 103
in a total
of 1 mL

1.8 x 106
in a total
of 1 mL

2.1 xlO 4
in a total
of 1 mL

7.6 x 104
in a total
of 1 mL

1.1 xlO 6
in a total
of 1 mL

1.5 xlO 6
in a total
of 1 mL

Transform
Efficiency
CFU/ug
DNA
* *

Titer
CFU
PermL

* Colony forming units = CFU
* Titer = CFU/mL = # colonies / (dilution) (0.1)
** Transformation efficiencies = CFU/mL x 1.1 mL / 0.5 ng x 10"3 yg / ng
•
•

TNTC = too numerous to count
After electroporation, 100 JJL of each transformation was serially diluted to 10"10.
From each dilution, 100 /jL of cells were plated onto LB/ampicillin plates
(50 /jg/mL) and incubated overnight at 37°C. The number of observed colonies for
each treatment and dilution is shown above. CFU/mL was calculated for the titer of
the original 1.1 mL of electroporated cells. Transformation efficiency was based on
the 0.5 ng of DNA used in each transformation.
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Amplification and Titer of GSE Library
The recombinant library with the 1:2 molar ligation ratio was amplified to a titer of
7.0 x 109 colony-forming units (CFU) per mL in a total volume of 35 mL to yield
2.45 x 10" CFUs total. A comparison of the GSE library before amplification and after
amplification shows a marked increase from 1.5 x 106 CFUs in a total of 1 mL to
2.45 x 1011 CFUs in a total of 35 mL and 7.0 x 109 colony-forming units CFUs per mL.
These figures represent a 4,666 fold increase of CFUs per mL of GSE library and a
163,333 fold increase overall.

Analysis of the GSE Library
From the amplified GSE library, DNA from 2 clones were isolated and cut with a
EcoR I / Hind III double digest to reveal an average insert size of 60 bp. With this insert
size and a total CFU in the unamplified library of 1.5 x 106, the current GSE library is
200 % representative of the E. coli genome.

Screening of the GSE Library
The GSE library was screened by plating a 100 juL aliquot of 1/100,000,000 diluted
genomic DNA library stock onto 20 LB agar plates containing ampicillin (50 ^g/mL).
These plates were grown overnight at 37°C and used as master plates. Colonies from the
master plates were transferred to sterile velveteen squares and were replica plated onto
two minimal agar plates, one with EPTG and one without IPTG.
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Plates were grown overnight at 37°C and colony growth on the minimal plates with IPTG
were compared to the colony growth on the minimal plate without IPTG to determine if
genetic suppression had occurred.
Those colonies on the plates containing IPTG that did not grow or that grew slower
than colonies on the plates without IPTG were isolated for further analysis. A total of 850
colonies were screened resulting in 12 colonies expressing GSE characteristics.

Characterization of Potential GSE Clones by Restriction Digestion
DNA was isolated from the 12 colonies that exhibited slow growth or no growth in the
presence of IPTG. DNA from each colony was digested with EcoR I and Hind III (New
England Biological) to excise any insert ligated into the BamH I site. Restriction digests
revealed that 2 of the colonies harbored detectable inserts. These colonies, A21 and A41,
were chosen to be sequenced. DNA from both colonies was isolated and analyzed by
restriction digest once more.
Figure 9 shows the restriction patterns of the plasmids isolated from the colonies A21
and A41. The plasmid isolated from the A21 colony produced a fragment of
approximately 120 bp when double digested with EcoR I / Hind III and no detecable
fragments when digested with EcoR I or Hind III alone. Also, digestion of the A41
plasmid with EcoR I/Hind III double digest produced a fragment of approximately 90 to
100 bp. Digestion with EcoR I or Hind III alone did not yield any detectable fragments
for the A41 plasmid.
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Characterization of Potential GSE Clones by DNA Sequencing
DNA sequencing was used to further characterize the plasmids isolated from the
colonies A21 and A41. DNA sequencing was initiated using a primer specific for the T7
or the SP6 RNA polymerase promoters that lie on opposite sides of the multiple cloning
site into which GSE fragments were inserted. The sequencing data in figure 10 shows
that the A21 vector harbors a 76 bp insert. Comparison of the A21 DNA sequence to the
E. coli genomic sequence database (56) determined that colony A21 matched 20 E. coli
genes. However, the sequence matches between the A21 insert and the E. coli genes
contained approximately 13 % undetermined bases or N's. Subsequently, no further
investigation was performed until additional sequencing could be done.
The A41 complete transcript harbors a 44 bp insert (Figure 11) and matches seven E.
coli genes (Table 3). The bases that matched these genes all lie within the insert sequence
of A41.Upon further analysis the A41 transcript potentially binds to all seven E. coli
genes in the antisense orientation. Also, all A41 binding sites are GC rich and some have
identical binding sequences. Examination of the location and interaction between the A41
transcript and each individual mRNA produced by these genes was essential to
understanding the processes for potential gene suppression.

Determination of Antisense Inhibition Mechanism
To determine the possible mechanisms involved in the suppression of each of the
seven mRNA transcripts, the location and potential secondary structure was determined.
Examination of each of the seven A41 binding sites showed that they are located in the
coding domains of each of the genes (Figure 12). These findings eliminate the class la
mechanism that requires binding of antisense RNA such that it overlaps the Shine-

40

Dalgarno ribosomal-binding site. It also eliminates the class II mechanism that requires
binding upstream of the ribosomal-binding site. Left, then, is the possibility of a class lb
mechanism, in which antisense RNA binds to the coding region and destabilizes it by
increasing nuclease degradation of the mRNA, the class III mechanism, in which binding
of the antisense RNA induces premature transcriptional termination by mimicking a
transcription termination site. Since this study did not include a northern analysis to
determine the size or stability of target mRNAs, the possibility that a class lb mechanism
is the source of inhibition can not be eliminated. However, analysis of the predicted
secondary structure with and without antisense RNA bound to potential target sites will
allow us to predict if a class III type of inhibition is a possible mechanism. Such
predictions can be confirmed by a northern analysis.

Characterization of Potential GSE Mechanisms by RNA Secondary
Structure Analysis
It must be noted that a predicted RNA structure for each gene must incorporate
approximately 500 bases to be 73 % accurate. Therefore, the RNA secondary structures
predicted here for each gene may or may not exist in nature. The intention is to illustrate
the localized (50 to 60 bp) mRNA secondary structure of each gene in its unbound state
and to show the subsequent disruption of local mRNA secondary structure for each gene
when the A41 transcript is bound. These steps must be done to confirm the presence, if
any, of structural interruptions occurring because of the antisense RNA binding.

41

A41
A

B

C

A21
D

A

B

C

D

3000 bp 2000 bp 1600 bp -

1000 b p -

500 b p -

200 bp100 bp75 bp-

Figure 9. Electrophoresis of restriction digest products from the plasmids isolated
from the colonies A41 and A21. Digestions were electrophoresed on a 0.8% agarose gel
for 1 hour at 100 volts. The first and last lanes consist of lkb marker (BRL). Digests were
ordered on the gel as follows: (A) uncut plasmid, (B) EcoR 1 digest, (C) Hind III digest
and (D) double digest with EcoR I and Hind III.
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A21 Full TruiA0x3.pt

bKcoK I

Half B«JHH I

T7 Proraotar

Insert

TA
I ATACGACTCACTATAGGGAGACCGG AATTCOAGCTCGGTACCCGGQ
XTTXTGCTGXSTGXT»T
. CCXrCTIJGCCTTAX GCTCGXGCCXTOSGCCCCTAG GA^tTCTCKSCTTTNCGTCCGTACaCCCGGNNTTCTTHNCC
Ball B«mH I

Bind III

Xnaart

ATTHACTN^GOTOTTCWCTCMTTTTCGGG GATCCTCTAGAGTCGACCTGCACGCATGCA AGCTTCASTATTCTATAGTGTCACCTAAATC
TAANTGAMCNCCHOC
t COACCCXAAAGCCCCTAa (^0*TCTCJLGCT0G»CGTCCCT*CGTTCS» ACTCATAAGATATCACAQTGGATTTAG
SP6 Promoter

T7 Taminator Start
GGTC(3AACTAJ5GCCGACGATTGTTTCGGGCT ITCCTTCGACTCAXCCGACGACGGTGGCCSACTCGTTATTCA
i rG
i TA
CCA«^T<»TCra»OTCCT»A£AAAIKCCaUUUMAAGCT«^^

3'

gGGGCCTCTAAACGflCTCTTSAGCG^l' TTJ. TG
i CTSKAAGGACGAHCT
CCCCGGAGAT
.TTGCCCAA
it.ACGCCCCAAAAAACGAC
. TTTCCTCCANGA

Figure 10. A21 Full Transcript Sequence: A21 plasmid DNA sequence was determined
using the T7 RNA and the SP6 polymerase promoter primers. The A21 insert contains
13 % unknown bases that are incorporated within the sections of the insert that possibly
bind to 20 E. coli genes.
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A«1 Full Transcript.
5'
EcoR ? fit*
Half ButH 1 HU
Hfclf ButK I uta
T7 Profnot»r
Insert
ATTAATACSACTCACTATAOOSAaACCCC AATTCGAGCTCGOTACCCGGG (»TCOIu:CGCCGCCCGCGO«»KJlTCCCGJlGCTGCGCTC GATCCTCT
TAATTATGCTGAGTGATATCCCTCTGGCCTTAA GCTCGAGCCATGCGCCCCTA:iCTGCCCOCGGGCGCGCCGCGTACCSCTCGJiCGCQASCTJlGCASA

Hind III iiu
ASAGTCGACCTGCAOGCATGCA AGCTTGAGTACTCTATAGTGTCACCTAAATCCCAGCW(^TCCG<2CTGCTAACAAAC
flCCGAAAXMAAGCTGAGTTG
TCTCAGCTGOACGTCCGTACGITCGA ACTCATAAaiTATCACACTG^TTTAC
j SGGTCGAACTAGCCCOACSATTCOTTCSGCC
'lC
'lC
'l' TTCGACTCAAC
SP€ prcoot«r

T7 Ternunator
BCrGCTOCCACgSCTliA^

-

CC^GACaGTOGCGACTaTrTATTraTa^TTRXraUUX^

Figure 11. A41 Full Transcript Sequence: A41 plasmid DNA sequence was determined
using the T7 and the SP6 RNA polymerase promoter primers.

Table 3. Possible gene matches between the A41 transcript and the E. coli genome

Gene

rtarZ
narG
fepG
Ihr
yahl
yxfG
ycjQ

Function
Energy metabolism carbon,
anaerobic respiration
Energy metabolism carbon,
anaerobic respiration
Transport: transport of small
molecules
Enzyme, DNA replication and
repair
Putative enzyme
Putative enzyme
Putative enzyme

Product
Cryptic nitrate reductase 2
Alpha subunit
Nitrate reductase 1
Alpha subunit
Ferric enterobactin
Transport protein
Member of ATP-dependent
Helicase superfamily n
Putative kinase
Putative enzyme
Putative oxidoreductase
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lhr

SD

A41
4617 bp

narG

SD

A41.
3743 bp

narZ

?D

A41.
.3740 bp

SD

fepG

,A41
. 932 bp

ysrc

SD

A41.
.827 bp

SD

ycjQ

•A41
.1057 bp

yahl

SD

1

A41.
-950 bp

Figure 12. Area of localized binding of the A41 Transcript to each of the seven E.
coli mRNAs

The lhr gene codes for a 4617 bp mRNA transcript that functions as an enzyme. It is a
member of the ATP-dependent helicase super family II and is involved in DNA-repair,
replication, restriction and modification. Localized folding of the lhr transcript in its
unbound state produces a short lead sequence followed by two stem loop structures. The
stem loop structures are bonded together at the 3' end of the first stem loop to the 5' end
of the second stem loop. (Figure 13). Localized folding for the lhr transcript in its bound
state show a marked difference in secondary structure (Figure 14). When bound by the
A41 transcript, thelhr transcript is folded into a structure that combines the two stem
loop structures that are seen in figure 13. A two base section follows the stem loop
structure and precedes the area of complementary base pairing between thelhr transcript
and the A41 transcript. Nine A/U's follows the bound region at the 3' end of the
transcript. The interaction between the A41 transcript and th elhr transcript has the
characteristics of Class III antisense mechanisms. Binding of the A41 transcript induces
a change in thelhr mRNA secondary structure and produces a long GC rich stem
structure. This change in secondary structure from a short (6 bp) GC rich stem loop to a
very long (15 bp) GC rich stem structure which may cause the RNA polymerase to stall
and possibly dissociate because of the 9 contiguous A U base-pairs following the mRNA
duplex. Such premature transcriptional termination would produce a truncated protein
that would consist of only its N-terminal domain of the protein.
The narG gene codes for a 3743 bp mRNA transcript that functions as an enzyme. It
codes for the alpha subunit of nitrate reductase 1 and is used for energy metabolism.
Localized folding of the narG transcript produces a complex secondary structure (Figure
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15). The A4I transcript binds within the middle of the narG transcript were localized
folding for the narG transcript in its A41 hybridized state shows a distinctly different
secondary structure (Figure 16). When bound by the A41 transcript, the narG transcript
is folded into a structure that combines the two stem loop structures that are seen in figure
15. The area of complementary base pairing between and the A41 transcript the narG
transcript closely follows the stem loop structure and precedes a section rich in Gs and
Cs. Binding of the A41 transcript to the narG transcript would have the characteristics of
a Class III antisense mechanism if the sequence following the duplex were A/U rich;
however, the 10 bases following the duplex are 70% GC and therefore would not be an
effective Rho-independent terminator.
The narZ gene codes for a 3740 bp mRNA transcript that functions as an enzyme. It
codes for the alpha subunit of the cryptic nitrate reductase 2 and is used for energy
metabolism. Localized folding of the narZ transcript produces a complex secondary
structure (Figure 17). The A41 transcript binds within the middle of the narZ transcript
were localized folding for the narZ transcript when bound to A41 shows a distinct
difference in secondary structure (Figure 18). When bound by the A41 transcript, the
narZ transcript is folded into a structure that combines the two stem loop structures
shown in figure 17. The A41 and the narZ transcripts precede a 10 bp section of single
stranded RNA that is 70 % G/G and would not serve as a Rho-independent terminator.
The fepG gene codes for a 932 bp mRNA transcript that functions as a protein. It
codes for the ferric enterobactin transport protein and is used for the transport of small
molecules. Localized folding of the fepG transcript produces a complex secondary
structure (Figure 19). The 5'end consists of a large hairpin with three bulges and the 3'
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end has a short hairpin. The A41 transcript binds 200 bp downstream of t h e f e p G
transcript's 5* end where localized folding for t h e f e p G transcript when bound to A41
shows a similar secondary structure (Figure 20) with only the 3' stem-loop removed.
Base pairing between and the A41 transcript and the fepG transcript precedes a section of
single stranded bases that are 60 % A/U. Even though the stem region is strong and GC
rich, this single stranded tail would not be sufficiently weak to allow Rho-independent
transcriptional termination.
Th eygfG gene codes for an 827 bp mRNA transcript that has a putative function and
codes for a putative enzyme. Localized folding of th eygfG transcript produces a complex
secondary structure (Figure 21) that is a long stem-loop structure with interior bulges.
The A41 transcript binds 80 bp upstream of the ygfG transcript's 3' end where localized
folding for the ygfG transcript hybridized to the A41 shows a distinctly different
secondary structure (Figure 22). When bound by the A41 transcript, the ygfG transcript
is folded into a structure that shortens the original stem structure by eliminating the first
four bulges and creates a long 5' leader sequence. The area of complementary base
pairing between the A41 transcript and th eygfG transcript is bound directly to the base of
the stem loop structure and precedes a section of single stranded RNA that has a 60 %
A/U composition. The A41 transcript binds close to the 3' end of the ygfG transcript and
only 110 bp upstream from t h e y g f H start site. The close proximity upstream to the ygfH
start site affords a possibility of class II suppression of the ygfH gene.
The ycjQ gene codes for a 1052 bp mRNA transcript that has a putative function and
codes for a putative oxidoreductase. Localized folding of the ycjQ transcript produces a
small hairpin loop structure that is bound adjacent to a larger hairpin loop. (Figure 23).
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Ihe A4i transcript binds 205 bp downstream of the yc/O transcripts 5" start site where
localized folding for the yc/O transcnpt in its A41 hybridized state (Figure 24) produces
a structure that combines the original two hairpin loops into one GC rich hairpin. The
A41 transcript and the ycj(J transcripts are "bound together three nucleotides from the base
of the hairpin loop structure and form a G/C rich 14 bp hybrid. The 10 "bases downstream
of this hybrid are 70 % A/U rich.
The yahl gene is a 950 bp mRNA transcript that codes for a putative kinase. Localized
folding of Xheyahl transcript produces a large hairpin loop structure (Figure 25). The
A41 transcript "binds 350 bp upstream of the yahl transcripts 3' end were localized
folding for the yah] transcnpt in its A41 hybridized state (Figure 26) rearranges the
folded structure into AU rich hairpin. The A41 and the yahl transcripts are "bound
together 1 nucleotide from the base of the hairpin loop structure and form a 14 bp hybrid.
The i0 "bases following the hybrid are only 40 % A/U rich and would not serve as a Rhoindependent termination site.
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Discussion
Plasmid based clones of genetic suppressor elements (GSEs) encoding either
dominant negative mutants or inhibitory antisense RNA sequences can be generated from
randomly fragmented DNA and selected by observed suppression of functional gene
expression (2). The goal in this study was to determine if gene inhibition in E. coli
JM109DE3 cells could be achieved through GSEs generated from randomly fragmented
genomic DNA and whether these GSEs can be used to locate and determine the function
of unknown genes. The results suggest that it is possible to use genetic suppressor
elements to inhibit gene function in bacterial cells and to isolate genes with unknown
function.
Data in figure 7 demonstrated that a selection of DNA fragments ranging in size from
approximately 50-1500 bp were cut and isolated from genomic DNA. Figure 8, lane 12,
shows that these fragments were successfully ligated into the pAV vector, and Table 2
shows transformation results that predict that 90 % of the 1.5 x 106 initial clones were
recombinant. Amplification of the GSE library increased this amount to a total of 2.45 x
10 n CFUs. Screening of the library for auxotrophic genetic suppressors revealed 2
independent GSE isolates out of 850 colonies. To truly characterize this library, a gene
that represents a certain percentage of the entire E. coli JM109DE3 genome would be
used to probe the library. This gene probe would determine if the library contained the
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proper proportion of this particular gene. This procedure was not done due to the lack of
time.
A DNA sequencing analysis of each GSE isolate determined that A21 harbored an
insert of 76 bp (figure 10) and matched to 20 E. coli genes. However the probability of
these matches occurring by chance was very high. The area of concern for the A21 insert
was that it contained 13 % unknown base pairs within the section of sequences that
matched to the 20 E. coli genes. These unknown bases produced less accurate sequencing
data to be matched against the E. coli genome database. The fact that JM109DE3 E. coli
cells that harbored the A21 transcript exhibited GSE suppression characteristics suggests
the A21 insert produced a GSE. More accurate sequencing data will be needed to
determine if the A21 insert can match to E. coli genes and significantly decrease the
probability of chance.
The A41 transcript contained a 44 bp insert (Figure 11) and was found to be
complementary in sequence to seven different E. coli genes. Examination of the localized
RNA secondary structure folds for each gene located the area of complementary base
pairing of the A41 insert. Analysis of this site for each RNA structure allowed the
opportunity to establish a possible antisense RNA mechanism. In all of the seven genes
analyzed, the A41 antisense RNA was found to hybridize within the coding region for
each gene. These data eliminated the Class la and Class II antisense RNA mechanisms.
Antisense inhibition of all seven genes by the A41 transcript may occur through
cleavage of the mRNA/antisense RNA duplex by RNaselll (Class lb). Antisense control
of AcII expression by the oop antisense RNA appears to result exclusively from RNaselll
cleavage of the target mRNA / antisense RNA complex (25, 29, 44). RNaselll
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participates in the maturation and decay of cellular and viral transcripts by degrading
double-stranded RNA. Also, RNase III degradation is inherent to most antisense RNAregulated gene systems in E. coli (70). The typical cleavage sites for RNase III are the
internal loops found within a stem-loop structure (71). The RNA secondary structures for
each of the seven genes that are bound by the A41 insert (Figures 14, 16, 18, 20, 22, 24,
26) show that each form a stem-loop which have internal loops incorporated. These sites
provide a possible cleavage site for RNase III.
The last antisense RNA mechanism to be considered is Class III. Here, antisense
RNAs bind to a target sequence and disrupt the nascent mRNA secondary structure so
that transcription is inhibited by a mechanism similar to transcriptional attenuation. In
nature, a complex mechanism is proposed for the pT181 antisense RNA, where antisense
RNA binding causes a detrimental conformational change in the mRNA (25).
According to Wilson and von Hippel (72), the optimal hairpin dimensions for
maximizing termination efficiency for intrinsic, rho-independent terminators consist of a
stem structure with 8 or 9 mostly GC base pairs and a loop of 4 to 8 bp. They also found
that lengthening or shorting the stem beyond these limits would decrease or abolish
terminator activity. Another important characteristic that Wilson and von Hippel
detected was that the site of termination is invariant, meaning that in each variation of a
wild-type terminator (tR2) that they had tested, termination occurred at the exact same
position. This area was within or at the end of a stretch of U's located on the 3' end of the
hairpin where termination always occurred at the 7th and 8th U (72).
The data of Wilson and Hippel was used to determine if the hairpin structures
produced in this study were true Class III rho-independent terminators. Examination of
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all seven of the E. coli genes bound by the A41 insert determined that only lhr exhibits
some of the required characteristics for intrinsic termination. The hairpin structural
dimensions produced for the lhr (Figure 14) are as follows: 1) The stem structure
consists of 14 bp bonds where 12 of the bonds are GC. 2) The loop of the hairpin is made
up of 6 bp. 3) A stretch of 9 A/U incorporated adjacent to the A41/lhr mRNA hybrid
where the seventh and eighth residues are A A. The hairpin stem structure dimensions
exceed the 8 to 9 bp, but fall within the range of 4-8 loop bp with 6 bp. The seventh and
eighth residues downstream of the A41/lhr hybrid are A A and do not adhere to the
U7/U8 criteria. The comparison of the A41/lhr hybrid to the Wilson/ Hippel model
suggests that the probability of the A41/lhr hybrid acts as a Class III mechanism is low.
The hairpin stem is too long by Wilson/Hippel criterion and more importantly the
residues at the seventh and eighth positions adjacent to the 3' end of the hybrid are A A
vs U U. Wilson and Hippel suggest that the stretch of rUs downstream of the hairpin
stem is essential to provide the necessary level of RNA-DNA destabilization (72).
The insert size for both the A21 and A41 clones were unexpectedly short. Two
Factors were involved. First, the fractions of fragments isolated by size using the CL 4B
sepharose column were found to be between approximately 50 to 1500 bp (Figure 17).
Fraction 16 shown in figure 7 illustrates that there were small fragment sizes incorporated
into the pool of fragments collected and would allow a small vector such as the pAV used
in this study to ligate to the smaller fragments at a more efficient rate as opposed to the
larger fragments. Also, given that only a small fraction of the entire library was tested
would in itself be a factor in that the first clones detected would be those clones that
harbored the smallest fragments.

The data also shows that the insert for A41 did not match to any of the seven E. coli
genes 100 %. In fact, the A41 insert matched to each gene in the range of 32 %. For each
gene match, the A41 insert usually produced 14 to 15 bp that matched to each gene.
However, 78 % of the A41 insert matches to all seven genes. This fact suggests that the
insert may not be directly part of any of the seven genes coding sequence, but a piece of
DNA that contains 14-15 bp that match to each gene. If this is true, then the suggestion is
that a 100 % direct sequence match is not necessary to produce GSE inhibition. Also, the
JM109DE3 strain genomic sequence is not an exact match to the E coli strain (K12) that
was used for comparison in this study. This fact implies that the A41 insert may not
match totally in sequence because of the differences of genomic sequence between
strains.
The opportunity for further study exists in four principal areas. 1. Probe the library
with a representative gene which would determine if the library was representative of the
entire E. coli genome. 2. Northern Blots. Continued analysis of the A41 insert would
involve doing Northern blotting of the total cellular RNA in JM109DE3 cells to
determine which if any mRNA hybridize to a radio-labeled A41 antisense transcript.
Transcripts that hybridize would be monitored in uninduced and induced cells for length
and concentration differences indicative of premature transcriptional termination and
degradation. A class lb mechanism would show lower levels or even absence of
transcripts in IPTG induced cells compared to uninduced cells transcripts. A Class III
mechanism would show shorter transcripts in induced cells compared to uninduced cells,
and both the length and size of the transcript would help classify which of the seven
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genes were being affected. 3. Re-sequence the A21 insert. Re-sequencing the A21 insert
using purer DNA may help to determine the identity of the unknown bases that were
incorporated within the insert. If the unknown bases can be determined, then the A21
insert could match to E. coli genes better and significantly decrease the probability of
chance. 4. Further screening of the GSE library. In this study, 850 colonies were
screened and produced 2 possible GSEs that may suppress up to 27 different E. coli
genes. The 850 colonies screened represent less than 1 % of the total colonies to be
screened that constitute a representative library for an insert of 68 bp. Screening the
remaining 99 % of the representative colonies has the potential to produce 500 to 1000
separate GSEs. Some of these transcripts will undoubtedly harbor GSEs of various sizes
that work via the antisense and/or dominant negative mutant mechanisms. The
probability of finding a GSE that suppresses a gene with an unknown or putative function
can only increase with further screening of the GSE library produced in this study.
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